Regeneron Pharmaceuticals Inc (REGN):企業の製品パイプライン分析

◆英語タイトル:Regeneron Pharmaceuticals Inc (REGN) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME81628PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥172,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥258,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Regeneron Pharmaceuticals Inc (Regeneron) discovers, develops, manufactures, and markets medicines for the treatment of serious medical conditions. Its marketed and pipeline products are focused on helping patients suffering with eye diseases, cancer, allergic and inflammatory diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, and rare diseases. It develops products using its Trap and VelociSuite technology platforms, which include VelociGene, VelocImmune, VelociMouse, VelociMab, Veloci-Bi and other related technologies. The company operates manufacturing facilities in Rensselaer, New York and Limerick, Ireland. It also works in collaboration with strategic partners to develop, manufacture and commercialize its products. It sells its products to specialty pharmacies and distributors. The company and its subsidiaries operate in the US, Bermuda, the Netherlands, Ireland, Spain and the UK. Regeneron is headquartered in Tarrytown, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Regeneron Pharmaceuticals Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Regeneron Pharmaceuticals Inc Company Overview
Regeneron Pharmaceuticals Inc Company Snapshot
Regeneron Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
Regeneron Pharmaceuticals Inc – Pipeline Analysis Overview
Business Description
Regeneron Pharmaceuticals Inc – Key Facts
Regeneron Pharmaceuticals Inc – Major Products and Services
Regeneron Pharmaceuticals Inc Pipeline Products by Development Stage
Regeneron Pharmaceuticals Inc Pipeline Products Overview
DUPIXENT Pre-filled Syringe
DUPIXENT Pre-filled Syringe Product Overview
DUPIXENT Pre-filled Syringe – Adolescents
DUPIXENT Pre-filled Syringe – Adolescents Product Overview
DUPIXENT Pre-filled Syringe – Pediatric Atopic Dermatitis (6 mo-5 yr)
DUPIXENT Pre-filled Syringe – Pediatric Atopic Dermatitis (6 mo-5 yr) Product Overview
DUPIXENT Pre-filled Syringe – Pediatrics (6-11 years)
DUPIXENT Pre-filled Syringe – Pediatrics (6-11 years) Product Overview
Injectable Drug Delivery Device
Injectable Drug Delivery Device Product Overview
Regeneron Pharmaceuticals Inc – Key Competitors
Regeneron Pharmaceuticals Inc – Key Employees
Regeneron Pharmaceuticals Inc – Key Employee Biographies
Regeneron Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Regeneron Pharmaceuticals Inc, Recent Developments
Sep 05, 2020: Kaskela Law announces investigation of Regeneron Pharmaceuticals (Regn) and encourages long-term Regn stockholders to contact the firm
Jun 24, 2020: Kymab wins Supreme Court case against Regeneron
Jun 03, 2020: Kymab announces that the US Patent Trial and Appeal Board rejects a fifth request by Regeneron for invalidation of Kymab’s US patents
Apr 14, 2020: Kymab announces that the US Patent Trial and Appeal Board rejects requests for invalidation filed by Regeneron
Feb 08, 2020: EYLEA (aflibercept) injection reduced risk of developing vision-threatening events by 75% after two years in patients with diabetic retinopathy
Feb 06, 2020: Regeneron reports fourth quarter and full year 2019 financial and operating results
Jan 23, 2020: Bayer submits application to European Medicines Agency for pre-filled syringe to administer eye medication Eylea
Jan 08, 2020: Publication highlights Regeneron’s costimulatory bispecific antibodies, an emerging class of cancer immunotherapy
Dec 12, 2019: Regeneron and Cold Spring Harbor Laboratory unveil new dedicated laboratories for student science education
Nov 22, 2019: Regeneron’s Yancopoulos receives Columbia College’s Alexander Hamilton Award
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Regeneron Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
Regeneron Pharmaceuticals Inc Pipeline Products by Equipment Type
Regeneron Pharmaceuticals Inc Pipeline Products by Indication
Regeneron Pharmaceuticals Inc, Key Facts
Regeneron Pharmaceuticals Inc, Major Products and Services
Regeneron Pharmaceuticals Inc Number of Pipeline Products by Development Stage
Regeneron Pharmaceuticals Inc Pipeline Products Summary by Development Stage
DUPIXENT Pre-filled Syringe - Product Status
DUPIXENT Pre-filled Syringe - Product Description
DUPIXENT Pre-filled Syringe - Adolescents - Product Status
DUPIXENT Pre-filled Syringe - Adolescents - Product Description
DUPIXENT Pre-filled Syringe - Pediatric Atopic Dermatitis (6 mo-5 yr) - Product Status
DUPIXENT Pre-filled Syringe - Pediatric Atopic Dermatitis (6 mo-5 yr) - Product Description
DUPIXENT Pre-filled Syringe - Pediatrics (6-11 years) - Product Status
DUPIXENT Pre-filled Syringe - Pediatrics (6-11 years) - Product Description
Injectable Drug Delivery Device - Product Status
Injectable Drug Delivery Device - Product Description
Regeneron Pharmaceuticals Inc, Key Employees
Regeneron Pharmaceuticals Inc, Key Employee Biographies
Regeneron Pharmaceuticals Inc, Other Locations
Regeneron Pharmaceuticals Inc, Subsidiaries
Glossary

★海外企業調査レポート[Regeneron Pharmaceuticals Inc (REGN):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PTC Inc (PTC):企業の財務・戦略的SWOT分析
    PTC Inc (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dongbu Corporation:企業の戦略・SWOT・財務情報
    Dongbu Corporation - Strategy, SWOT and Corporate Finance Report Summary Dongbu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Abu Dhabi Water & Electricity Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Water & Electricity Authority (ADWEA) is a government-owned organization provides utility services. The authority researches and develops methods for the production, distribution and consumption of water and electricity efficiently. Through subsidiaries, ADWEA conducts generation, …
  • Electronic Arts Inc.:企業の戦略・SWOT・財務分析
    Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Arts Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • ThyssenKrupp AG:企業の戦略・SWOT・財務分析
    ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report Summary ThyssenKrupp AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Hunt Oil Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Hunt Oil Co (Hunt Oil), a subsidiary Hunt Consolidated, Inc., is an independent upstream company. It carries out exploration, production and development of oil and natural gas. In the US, it has acreage and active programs in the Williston Basin (Bakken) of North Dakota, the Permian Basin of …
  • Trillium Therapeutics Inc (TRIL):製薬・医療:M&Aディール及び事業提携情報
    Summary Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, is a clinical stage immuno-oncology company, which develops novel therapies for the treatment of cancer. The company’s lead program, TTI-621, a SIRPaFc fusion protein is being developed for hematological malignancies. …
  • I Grandi Viaggi Spa:企業の戦略・SWOT・財務分析
    I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report Summary I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hewlett Packard Enterprise Company:企業の戦略・SWOT・財務情報
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • WInco Foods LLC:戦略・SWOT・企業財務分析
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TenneT Holding BV-エネルギー分野:企業M&A・提携分析
    Summary TenneT Holding BV (TenneT), owned by the Ministry of Finance of The State of the Netherlands, is an electricity transmission system operator. The company offers electricity transmission and system services. It constructs and maintains high voltage grid to transmit electricity from the produc …
  • Magellan Midstream Partners, L.P.:企業の戦略・SWOT・財務情報
    Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor th …
  • IMAX Corporation:企業のM&A・事業提携・投資動向
    IMAX Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IMAX Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • SpareBank 1 Nord-Norge:企業の戦略・SWOT・財務分析
    SpareBank 1 Nord-Norge - Strategy, SWOT and Corporate Finance Report Summary SpareBank 1 Nord-Norge - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PT Tempo Scan Pacific Tbk (TSPC):企業の財務・戦略的SWOT分析
    PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆